Skip to Main Content
Volastra
Menu Button
About
Pipeline
Team
Join
News
Contact
News
Category:
In the News
Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor
March 7, 2023
BioSpace
Volastra licenses Amgen molecule for chromosomally unstable cancers
March 7, 2023
C&EN
Armed with $60M series A and Lilly’s backing, Volastra enters clinic via Amgen cancer med
March 7, 2023
Fierce Biotech
Oncology specialist Volastra brings in PhI drug from Amgen, nabs $60M in Series A
March 7, 2023
Endpoints News
On heels of landmark approval, Bristol Myers Squibb embarks on billion-dollar oncology deal with metastatic cancer startup
March 21, 2022
Endpoints News
Load More
